行情

LMNX

LMNX

路明克斯
NASDAQ

实时行情|Nasdaq Last Sale

33.12
-7.38
-18.22%
盘前: 34.00 +0.88 +2.66% 08:36 08/07 EDT
开盘
39.91
昨收
40.50
最高
40.65
最低
32.90
成交量
191.13万
成交额
--
52周最高
41.69
52周最低
17.35
市值
15.08亿
市盈率(TTM)
367.59
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测LMNX价格均价为38.33,最高价位48.00,最低价为25.00。

EPS

LMNX 新闻

更多
Luminex (LMNX) Q2 Earnings Beat Estimates, Revenues Miss
Luminex (LMNX) witnessed total sample-to-answer molecular diagnostics revenue growth in Q2
Zacks · 1天前
Luminex Corp (DE) (LMNX) Q2 2020 Earnings Call Transcript
Image source: The Motley Fool. Luminex Corp (DE) (NASDAQ: LMNX)Q2 2020 Earnings CallAug 4, 2020, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, ladies and gentlemen, and welcome to the Lumi
Motley Fool · 2天前
Luminex EPS beats by $0.17, beats on revenue
Luminex (NASDAQ:LMNX): Q2 GAAP EPS of $0.27 beats by $0.17. Revenue of $109.52M (+31.9% Y/Y) beats by $2.19M. Shares +3.5%. Press Release
seekingalpha · 2天前
Luminex (LMNX) Q2 Earnings Surpass Estimates
Luminex (LMNX) delivered earnings and revenue surprises of 237.50% and -0.07%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 2天前
Luminex Scores Relative Strength Rating Upgrade
Luminex saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 89 to 92. When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength. Luminex is within a buying range aft
Investor's Business Daily · 2天前
Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of Directors
Luminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, G. Walter Loewenbaum, from its Board of Directors ("Board") effective August 3, 2020.
PR Newswire · 2天前
Luminex Sees Q3 Sales At or Above $100M Vs. $89.47M Est.; Sees FY20 Sales At or Above $415M Vs. $386.99M Est.
Benzinga · 2天前
Luminex Q2 EPS $0.27 Beats $0.08 Estimate, Sales $109.50M Beat $107.33M Estimate
Luminex (NASDAQ:LMNX) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.08 by 237.5 percent. This is a 370 percent increase over losses of $(0.10) per share from the same
Benzinga · 2天前

所属板块

先进医疗设备和技术
-0.95%
医疗设备和用品
-0.94%

热门股票

代码
价格
涨跌幅

LMNX 简况

Luminex Corporation开发、制造和销售用于诊断、制药和生命科学行业应用的生物测试技术。该公司拥有一系列使用其xMAP技术的仪器,包括其提供100-plex测试的LUMINEX 100/200系统、该公司的高通量FLEXMAP 3D系统、500-plex测试系统及其使用成像而非流式细胞术提供50-plex测试的MAGPIX系统。通过使用其xMAP技术,最终用户能够为每个样本同时生成多个结果。该公司主要通过向各种类型的测试实验室销售测试设备和实验等产品,为诊断、制药和生命科学行业提供服务。该公司的实验产品专注于分子诊断测试市场的三个部门:人类遗传学、个体化治疗和传染病。
展开

微牛提供Luminex Corporation(NASDAQ-LMNX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的LMNX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易LMNX股票基本功能。